Page last updated: 2024-11-07

estrone and Hypertrophy, Left Ventricular

estrone has been researched along with Hypertrophy, Left Ventricular in 1 studies

Hydroxyestrones: Estrone derivatives substituted with one or more hydroxyl groups in any position. They are important metabolites of estrone and other estrogens.

Hypertrophy, Left Ventricular: Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.

Research Excerpts

ExcerptRelevanceReference
" Although angiotensin converting enzyme inhibition has been shown to prevent progression of the disease in postmenopausal women, the interaction of angiotensin II and estrogen in this process before and after the menopause is poorly understood."3.70Angiotensin converting enzyme inhibition modulates cardiac fibroblast growth. ( Grohé, C; Kahlert, S; Löbbert, K; Neyses, L; Stimpel, M; van Eickels, M; Vetter, H, 1998)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grohé, C1
Kahlert, S1
Löbbert, K1
Neyses, L1
van Eickels, M1
Stimpel, M1
Vetter, H1

Other Studies

1 other study available for estrone and Hypertrophy, Left Ventricular

ArticleYear
Angiotensin converting enzyme inhibition modulates cardiac fibroblast growth.
    Journal of hypertension, 1998, Volume: 16, Issue:3

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Division; Cells, Cultured; C

1998